Another study reported no difference in breast cancer specific survival for TNBC gBRCAm versus gBRCAwt, but a worse breast cancer specific survival for estrogen receptor positive gBRCAm versus gBRCAwt. This evidence concerns the gene ESR1 and breast cancer.